These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 11757749)
1. Preventive antitumor activity against hepatocellular carcinoma (HCC) induced by immunization with fusions of dendritic cells and HCC cells in mice. Homma S; Toda G; Gong J; Kufe D; Ohno T J Gastroenterol; 2001 Nov; 36(11):764-71. PubMed ID: 11757749 [TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of immunization with fusion of dendritic cells and hepatocellular carcinoma cells in mice. Zhang H; Zheng SS; Jiang GP; Wu LH; Zhu F; Yang ZL Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):235-40. PubMed ID: 15138117 [TBL] [Abstract][Full Text] [Related]
3. Dendritic cell-based immunotherapy for hepatocellular carcinoma. Onji M; Akbar F; Horiike N J Gastroenterol; 2001 Nov; 36(11):794-7. PubMed ID: 11757756 [No Abstract] [Full Text] [Related]
4. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma. Tatsumi T; Takehara T; Kanto T; Miyagi T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N Cancer Res; 2001 Oct; 61(20):7563-7. PubMed ID: 11606395 [TBL] [Abstract][Full Text] [Related]
5. Anti-tumor efficacy of a hepatocellular carcinoma vaccine based on dendritic cells combined with tumor-derived autophagosomes in murine models. Su S; Zhou H; Xue M; Liu JY; Ding L; Cao M; Zhou ZX; Hu HM; Wang LX Asian Pac J Cancer Prev; 2013; 14(5):3109-16. PubMed ID: 23803088 [TBL] [Abstract][Full Text] [Related]
6. CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo. Gonzalez-Carmona MA; Lukacs-Kornek V; Timmerman A; Shabani S; Kornek M; Vogt A; Yildiz Y; Sievers E; Schmidt-Wolf IG; Caselmann WH; Sauerbruch T; Schmitz V Hepatology; 2008 Jul; 48(1):157-68. PubMed ID: 18537185 [TBL] [Abstract][Full Text] [Related]
7. Induction of specific cytolytic T lymphocytes using fusions of hepatocellular carcinoma (HCC) patient-derived dendritic cells and allogeneic HCC cell line. Yin XY; Wang L; Lu MD; Li BJ; Huang JF Hepatogastroenterology; 2008; 55(81):155-9. PubMed ID: 18507097 [TBL] [Abstract][Full Text] [Related]
8. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12. Homma S; Komita H; Sagawa Y; Ohno T; Toda G Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514 [TBL] [Abstract][Full Text] [Related]
9. In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells. Koido S; Homma S; Hara E; Mitsunaga M; Namiki Y; Takahara A; Nagasaki E; Komita H; Sagawa Y; Ohkusa T; Fujise K; Gong J; Tajiri H J Transl Med; 2008 Sep; 6():51. PubMed ID: 18793383 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of spontaneous development of liver tumors by inoculation with dendritic cells loaded with hepatocellular carcinoma cells in C3H/HeNCRJ mice. Irie M; Homma S; Komita H; Zeniya M; Kufe D; Ohno T; Toda G Int J Cancer; 2004 Aug; 111(2):238-45. PubMed ID: 15197777 [TBL] [Abstract][Full Text] [Related]
11. Intratumoral neoadjuvant immunotherapy using IL-12 and dendritic cells is an effective strategy to control recurrence of murine hepatocellular carcinoma in immunosuppressed mice. Kayashima H; Toshima T; Okano S; Taketomi A; Harada N; Yamashita Y; Tomita Y; Shirabe K; Maehara Y J Immunol; 2010 Jul; 185(1):698-708. PubMed ID: 20498356 [TBL] [Abstract][Full Text] [Related]
12. [Antitumor effect of immunizations with fusions of dendritic and hepatocellular carcinoma cells in mice]. Zhang H; Zheng SS; Jiang GP; Zhou L; Xie HY Zhonghua Gan Zang Bing Za Zhi; 2004 Nov; 12(11):648-51. PubMed ID: 15623369 [TBL] [Abstract][Full Text] [Related]
13. [Immunization with dendritic cells infected with human AFP adenovirus vector effectively elicits immunity against mouse hepatocellular carcinomas]. Tan XH; Zhu Q; Liu C; Liu XL; Shao XT; Wei B Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):13-6. PubMed ID: 16737612 [TBL] [Abstract][Full Text] [Related]
14. Fusions of Tumor-derived Endothelial Cells with Dendritic Cells Induces Antitumor Immunity. Huang Y; Mao Q; He J; Su J; Peng Y; Liang W; Hu Z; Zhou S; Lu X; Zhao Y Sci Rep; 2017 Apr; 7():46544. PubMed ID: 28436481 [TBL] [Abstract][Full Text] [Related]
15. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells. Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200 [TBL] [Abstract][Full Text] [Related]
16. Induction of anti-tumor immunity by dendritic cells transduced with FAT10 recombinant adenovirus in mice. Yang Z; Wu D; Zhou D; Jiao F; Yang W; Huan Y Cell Immunol; 2015 Jan; 293(1):17-21. PubMed ID: 25461613 [TBL] [Abstract][Full Text] [Related]
18. Chen K; Wu Z; Zhao H; Wang Y; Ge Y; Wang D; Li Z; An C; Liu Y; Wang F; Bi X; Wang H; Cai J; Ma C; Qu C Cancer Immunol Res; 2020 Jan; 8(1):81-93. PubMed ID: 31666238 [TBL] [Abstract][Full Text] [Related]
19. Immunotherapy based on dendritic cells pulsed with CTPFoxM1 fusion protein protects against the development of hepatocellular carcinoma. Su H; Li B; Zheng L; Wang H; Zhang L Oncotarget; 2016 Jul; 7(30):48401-48411. PubMed ID: 27351282 [TBL] [Abstract][Full Text] [Related]